Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone + glimepiride tablets in type 2 diabetes mellitus
CTR20130110Phase 2Completed
- Sponsor
- Hebei Aierhaitai Pharmaceutical
- Start
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of glimepiride + pioglitazone in type 2 diabetes mellitus (T2DM), sponsored by Hebei Aierhaitai Pharmaceutical. Started Jan 2014; status: completed.
02
Drugs
glimepiride + pioglitazone
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20130110.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20130110.